|
Name |
(5S,8S,9R)-8-benzoyl-2-[(1S,2S)-1,2-dihydroxyhex-3-enyl]-9-hydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione
|
Molecular Formula | C22H25NO8 | |
IUPAC Name* |
(5S,8S,9R)-8-benzoyl-2-[(1S,2S)-1,2-dihydroxyhex-3-enyl]-9-hydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione
|
|
SMILES |
CCC=C[C@@H]([C@@H](C1=C(C(=O)[C@@]2(O1)[C@H]([C@@](NC2=O)(C(=O)C3=CC=CC=C3)OC)O)C)O)O
|
|
InChI |
InChI=1S/C22H25NO8/c1-4-5-11-14(24)15(25)16-12(2)17(26)21(31-16)19(28)22(30-3,23-20(21)29)18(27)13-9-7-6-8-10-13/h5-11,14-15,19,24-25,28H,4H2,1-3H3,(H,23,29)/t14-,15-,19+,21+,22+/m0/s1
|
|
InChIKey |
SLYDIPAXCVVRNY-BVCQXIBHSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | 139587871 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 431.4 | ALogp: | 0.5 |
HBD: | 4 | HBA: | 8 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 142.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 31 | QED Weighted: | 0.276 |
Caco-2 Permeability: | -5.259 | MDCK Permeability: | 0.00002280 |
Pgp-inhibitor: | 0.668 | Pgp-substrate: | 0.027 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.052 |
30% Bioavailability (F30%): | 0.919 |
Blood-Brain-Barrier Penetration (BBB): | 0.697 | Plasma Protein Binding (PPB): | 81.18% |
Volume Distribution (VD): | 0.794 | Fu: | 10.33% |
CYP1A2-inhibitor: | 0.017 | CYP1A2-substrate: | 0.698 |
CYP2C19-inhibitor: | 0.037 | CYP2C19-substrate: | 0.779 |
CYP2C9-inhibitor: | 0.026 | CYP2C9-substrate: | 0.029 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.097 |
CYP3A4-inhibitor: | 0.031 | CYP3A4-substrate: | 0.658 |
Clearance (CL): | 5.929 | Half-life (T1/2): | 0.132 |
hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.135 |
Drug-inuced Liver Injury (DILI): | 0.968 | AMES Toxicity: | 0.145 |
Rat Oral Acute Toxicity: | 0.226 | Maximum Recommended Daily Dose: | 0.01 |
Skin Sensitization: | 0.557 | Carcinogencity: | 0.135 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.135 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002724 | 1.000 | D08UMH | 0.279 | ||||
ENC003742 | 1.000 | D0Y7RW | 0.272 | ||||
ENC002116 | 0.670 | D07RGW | 0.267 | ||||
ENC002999 | 0.590 | D0B7OD | 0.263 | ||||
ENC003736 | 0.477 | D0E3WQ | 0.256 | ||||
ENC002521 | 0.323 | D0U5RT | 0.252 | ||||
ENC000888 | 0.297 | D0Z9NZ | 0.252 | ||||
ENC001726 | 0.296 | D0E9WO | 0.252 | ||||
ENC003270 | 0.287 | D0WV4M | 0.250 | ||||
ENC003889 | 0.285 | D0QQ6Q | 0.248 |